Adjuvant nivolumab plus ipilimumab for kidney cancer
Adjuvant therapy is medication that is given after surgery to [...]
Health-related quality of life with lenvatinib in combination with everolimus
Maintaining good health-related quality of life is important for all [...]
Nivolumab compared to cabozantinib as a second- or third-line treatment
This study looked at real world data from people with [...]
Cabozantinib plus nivolumab and ipilimumab delays progression in kidney cancer
Preliminary results from the COSMIC-313 clinical trial have ben released. [...]
Surgical treatment of metastatic kidney cancer
There were a number of studies presented at the European [...]
Statins improve the effectiveness of nivolumab for advanced kidney cancer
Statins are a group of medicines that can help lower [...]
Incidence and risk of unplanned conversion from partial to radical nephrectomy
Partial nephrectomy, where the part of the kidney containing the [...]
Papillary type I vs type II renal cell carcinoma
Papillary renal cell carcinoma (pRCC) is the second most common [...]
AUA 2022: Should everyone have adjuvant therapy after surgery for high-risk kidney cancer?
The 2022 American Urological Association (AUA) Annual Meeting included a [...]
ASCO 2022: Sequencing of kidney cancer medicines
During the American Society of Clinical Oncology (ASCO) Annual Meeting [...]
